Biomarker Lens

Common biomarkers

  • Hemoglobin
  • Glucose
  • ALT
  • Apolipoprotein B
  • C-Reactive Protein, Cardiac
  • Ferritin
  • Alb/Creat Ratio, Urine
  • Alkaline Phosphatase
  • FSH
  • T4,Free(Direct)

Biomarkers · Chemical

Creatine Kinase, MB

Primary unit
ng/mL
LOINC codes
13969-1
Tests that measure Creatine Kinase, MB
Labcorp 2, Quest Diagnostics 1

Tests

Check the catalog code, specimen, method and preparation for every test that measures Creatine Kinase, MB. Select up to five tests to compare them side by side.

Labcorp 2 tests

Single-analyte tests

  • Creatine Kinase (CK), MB 120816

    Serum · Fasting not stated · Turnaround 1 - 2 days

    Method and collection
    Method
    Electrochemiluminescence immunoassay (ECLIA)
    Preparation
    The MB isoenzyme of CK is most commonly elevated in acute myocardial infarction (AMI). In AMI, plasma CK-MB typically rises some four to six hours after the onset of chest pains, peaks within 12 to 24 hours, and returns to baseline levels within 24 to 48 hours. The pattern of serial CK-MB determinations is more informative than a single determination.
    Collection
    If a red-top tube is used, transfer separated serum to a plastic transport tube.
    Reference notes
    • Male: 0.0−10.4 ng/mL • Female: 0.0−5.3 ng/mL
    Labcorp catalog page

Panels that include this biomarker

  • Creatine Kinase (CK), MB and Total 002311

    2 analytes · Serum · Fasting not stated · Turnaround 1 - 3 days

    Method and collection
    Method
    CK total: kinetic, 340 nm spectrophotometric; CK-MB: immunochemiluminometric assay (ICMA)
    Preparation
    CK is most commonly elevated in acute myocardial infarction (AMI) in which it has its greatest usefulness. Collection of specimen at onset of symptoms to establish baseline values is needed. A patient at onset of acute myocardial infarction (AMI) will have normal results, but some patients reach medical attention at or beyond CK peak. To support the diagnosis of AMI, three CK isoenzyme determinations have classically been recommended, one on admission, a second 12 hours after admission, a third 24 hours after admission. Another at 48 hours may be needed. CK-MB usually peaks between 15 and 20 hours after the onset of a myocardial infarction. Pappas summarizes current literature regarding timing as follows. In non-Q wave, incomplete occlusion, nontransmural MI, CK-MB peaks on the average 15 hours from onset. In Q wave (complete occlusion) (transmural) infarction, CK-MB average peak is 17 to 20 hours after onset of symptoms. He emphasizes the importance of a sample for CK-MB drawn 16 hours after onset.1 When increased CK-MB values have returned to normal, CK isoenzyme determinations are usually no longer required.
    Reference notes
    See tables. Total CK (U/L) Age Male Female 0 to 7 d 59-1111 55-777 8 to 30 d 51−168 37−151 1 m to 1 y 57−301 50−263 2 to 12 y 53−229 45−198 13 to 17 y 53−446 32−182 18 to 50 y 49−439 32−182 51 to 80 y 41–331 32–182 >80 y 30–208 26–161 CK-MB (ng/mL): Male: 0.0–10.4 Female: 0.0–5.3
    Labcorp catalog page

Quest Diagnostics 1 test

Single-analyte tests

  • CK-MB (CK-2) 17581

    Serum · Fasting not stated

    Method and collection
    Method
    Chemiluminescence (CL)
    Reference notes
    0-5.0 ng/mL
    Quest Diagnostics catalog page

0 of 5 tests selected

Pick one more

Sources

Verify these ranges and sources

We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.

Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.